Intervention Development and Pilot Study to Prevent Untreated Native Hawaiian and Pacific Islander Opioid Use Disorder

NCT04898478 | Unknown Early Phase 1

• 1 other identifier: R34DA049989
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

This study will design and pilot/feasibility test a culturally grounded intervention to increase the treatment seeking of Pacific Islanders with opioid use disorders in formal services.

Conditions

Opioid-use Disorder

Outcome Measures

Primary Outcomes (1)

• Pacific Islander Knowledge Scale about Opioid Use Disorders and Treatment

  5-point scale designed by the team to assess Pacific Islander knowledge of opioid use disorder and treatment with items such as "What causes most OUDs? What are the different treatment options for PIs with OUDs"

  Up to 12 months

Secondary Outcomes (1)

• Pacific Islander Attitude Scale about Opioid Use Disorders and Treatment

  Up to 12 months

Study Arms (1)

Treatment Seeking Intervention for Pacific Islanders with Opioid Use Disorders

EXPERIMENTAL

This arm will consist of a behavioral intervention to increase treatment seeking among Pacific Islanders with opioid use disorders.

Behavioral: Treatment Seeking Intervention for Pacific Islanders with Opioid Use Disorders

Interventions

Treatment Seeking Intervention for Pacific Islanders with Opioid Use Disorders BEHAVIORAL

The investigators will design a culturally grounded treatment seeking intervention for Pacific Islanders with OUDs

Treatment Seeking Intervention for Pacific Islanders with Opioid Use Disorders

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Of Pacific Islander/Native Hawaiian or part-Pacific Islander/Native Hawaiian heritage.
• Live in Utah or Hawaii.
• For all lay Pacific Islander adult participants: must be over 18 years of age.
• Fluent (oral and reading) in English or Native Hawaiian.
• \- Presence of active OUD, as screened via 8-item Rapid Opioid Dependence Scale.

You may not qualify if:

• Are unwilling to participate,
• Fails to provide or retracts consent,
• Reside outside the target communities of Utah or Hawaii

Sponsors & Collaborators

• University of California, Riverside: lead

Study Sites (1)

UC Riverside

Riverside, California, 91784, United States

RECRUITING

MeSH Terms

Conditions

Opioid-Related Disorders

Condition Hierarchy (Ancestors)

Narcotic-Related Disorders; Substance-Related Disorders; Chemically-Induced Disorders; Mental Disorders

Central Study Contacts

Andrew Subica

CONTACT

8089369806; asubica@medsch.ucr.edu

Study Design

• Study Type: interventional
• Phase: early phase 1
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 13, 2021
• First Posted: May 24, 2021
• Study Start: November 1, 2021
• Primary Completion: April 30, 2023
• Study Completion: April 30, 2023
• Last Updated: June 9, 2022

Record last verified: 2022-04

Locations

US (1)